Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glycopyrronium add-on to indacaterol/mometasone for allergen-induced late asthmatic response
NL-OMON49783Phase 3Active, not recruiting
- Sponsor
- University Medical Center Groningen
- Start
- Sep 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of glycopyrronium, indacaterol and mometasone in asthma (2 arms), sponsored by University Medical Center Groningen. Started Sep 2020; status: active, not recruiting.
02
Drugs
glycopyrroniumindacaterolmometasone
03
Conditions
asthma
Beyond the preview
Go deeper on NL-OMON49783.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON49783.